title: Pyrithione-zinc Prevents UVB-induced Epidermal Hyperplasia by Inducing HIF-1alpha.
abstract: Epidermal keratinocytes overgrow in response to ultraviolet-B (UVB), which may be associated with skin photoaging and cancer development. Recently, we found that HIF-1alpha controls the keratinocyte cell cycle and thereby contributes to epidermal homeostasis. A further study demonstrated that HIF-1alpha is down-regulated by UVB and that this process is involved in UVB-induced skin hyperplasia. Therefore, we hypothesized that the forced expression of HIF-1alpha in keratinocytes would prevent UVB-induced keratinocyte overgrowth. Among several agents known to induce HIF-1alpha, pyrithione-zinc (Py-Zn) overcame the UVB suppression of HIF-1alpha in cultured keratinocytes. Mechanistically, Py-Zn blocked the degradation of HIF-1alpha protein in keratinocytes, while it did not affect the synthesis of HIF-1alpha. Moreover, the p21 cell cycle inhibitor was down-regulated after UVB exposure, but was robustly induced by Py-Zn. In mice repeatedly irradiated with UVB, the epidermis became hyperplastic and HIF-1alpha disappeared from nuclei of epidermal keratinocytes. However, a cream containing Py-Zn effectively prevented the skin thickening and up-regulated HIF-1alpha to the normal level. These results suggest that Py-Zn is a potential agent to prevent UVB-induced photoaging and skin cancer development. This work also provides insight into a molecular target for treatment of UVB-induced skin diseases.
authors.affiliation: Department of Pharmacology, Chungbuk National University College of Medicine, Cheongju 361-763, Korea.
authors.forename: Young-Suk
authors.initials: YS
authors.lastname: Cho
authors.forename: Kyung-Hoon
authors.initials: KH
authors.lastname: Lee
authors.forename: Jong-Wan
authors.initials: JW
authors.lastname: Park
references.citation: Prostate. 2007 Oct 1;67(14):1514-23
references.pmid: 17683079
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7987-92
references.pmid: 9653127
references.citation: Mol Pharmacol. 2008 Jul;74(1):70-81
references.pmid: 18426858
references.citation: Mol Biol Cell. 2002 May;13(5):1792-801
references.pmid: 12006670
references.citation: Free Radic Biol Med. 2007 Aug 15;43(4):546-56
references.pmid: 17640565
references.citation: EMBO J. 2004 May 5;23(9):1949-56
references.pmid: 15071503
references.citation: J Biol Chem. 2010 Feb 5;285(6):3651-3663
references.pmid: 19940151
references.citation: Mol Cell Biol. 2002 Oct;22(20):7004-14
references.pmid: 12242281
references.citation: Mutat Res. 2005 Apr 1;571(1-2):91-106
references.pmid: 15748641
references.citation: J Am Acad Dermatol. 2008 May;58(5 Suppl 2):S139-48
references.pmid: 18410800
references.citation: Skin Pharmacol Appl Skin Physiol. 2002 Nov-Dec;15(6):434-41
references.pmid: 12476017
references.citation: Mol Pharmacol. 2006 Dec;70(6):1856-65
references.pmid: 16940187
references.citation: Nat Rev Mol Cell Biol. 2004 May;5(5):343-54
references.pmid: 15122348
references.citation: J Biol Chem. 1995 Jan 20;270(3):1230-7
references.pmid: 7836384
references.citation: Am J Pathol. 2000 Jan;156(1):201-7
references.pmid: 10623668
references.citation: Genes Dev. 1998 Jan 15;12(2):149-62
references.pmid: 9436976
references.citation: Biochim Biophys Acta. 2008 Feb;1783(2):323-33
references.pmid: 18166158
references.citation: Int J Cosmet Sci. 2003 Aug;25(4):183-8
references.pmid: 18494899
references.citation: J Biol Chem. 2002 Aug 16;277(33):29936-44
references.pmid: 12052835
references.citation: Biochem Biophys Res Commun. 2000 Feb 16;268(2):652-6
references.pmid: 10679259
references.citation: J Dermatol Sci. 2003 Sep;32(3):171-9
references.pmid: 14507442
references.citation: J Biol Chem. 2002 Apr 26;277(17):15162-70
references.pmid: 11859074
references.citation: Carcinogenesis. 2006 Feb;27(2):225-31
references.pmid: 16123117
references.citation: Mol Cells. 2009 Dec 31;28(6):537-43
references.pmid: 19937142
references.citation: Am J Infect Control. 2005 Feb;33(1):15-22
references.pmid: 15685130